Fattori prognostici nelle metastasi ossee da carcinoma

American Cancer Society (2007) Cancer facts and figures 2007. American Cancer Society, Atlanta

Tokuhashi Y, Matsuzaki H, Toriyama S et al (1990) Scoring system for the preoperative evaluation of metastatic spine tumor prognosis. Spine 15:1110–1113

Karnofsky DA, Burchenal JH (1949) The clinical evaluation of chemotherapeutic agents. In: McLeod E (Ed.) Evaluation of chemotherapeutic agents. Columbia University Press, New York

Tomita K, Kawahara N, Kobayashi T et al (2001) Surgical strategy for spinal metastases. Spine 26:298–306

Hosono N, Ueda T, Tamura D et al (2005) Prognostic relevance of clinical symptoms in patients with spinal metastases. Clin Orthop 436:196–201

Oka H, Kondoh T, Seichi A et al (2006) Incidence and prognostic factors of Japanese breast cancer patients with bone metastasis. J Orthop Sci 11:13–19

Böhm P, Huber J (2002) The surgical treatment of bony metastases of the spine and limbs. J Bone Joint Surg Br 84:521–529

Katagiri H, Takahashi M, Wakai K et al (2005) Prognostic factors and a scoring system for patients with skeletal metastasis. J Bone Joint Surg Br 87:698–703

Hansen BH, Keller J, Laitinen M et al (2004) The Scandinavian Sarcoma Group Skeletal Metastasis Register. Survival after surgery for bone metastases in the pelvis and extremities. Acta Orthop Scand Suppl 75:11–15

Capanna R, Campanacci DA (2001) The treatment of metastases in the appendicular skeleton. J Bone and Joint Surg Br 83:471–481

Soloway MS, Hardeman SW, Hickey D et al (1988) Stratification of patients with metastatic prostate cancer based on extent of disease on initial bone scan. Cancer 61:195–202

Cheville JC, Tindall D, Boelter C et al (2002) Metastatic prostate carcinoma to bone: clinical and pathologic features associated with cancer-specific survival. Cancer 95:1028–1036

Galasko CS (1981) The anatomy and pathways of skeletal metastases. In: Weiss L, Gilbert AH (Eds.) Bone metastasis. MA, Boston pp 49–63

Dürr HR, Müller PE, Lenz T et al (2002) Surgical treatment of bone metastases in patients with breast cancer. Clin Orthop 396:191–196

Koizumi M, Yoshimoto M, Kasumi F et al (2003) Comparison between solitary and multiple skeletal metastatic lesions of breast cancer patients. Ann Oncol 14:1234–1240

Jimeno A, Amador ML, González-Cortijo L et al (2004) Initially metastatic breast carcinoma has a distinct disease pattern but an equivalent outcome compared with recurrent metastatic breast carcinoma. Cancer 100:1833–1842

Jung ST, Ghert MA, Harrelson JM, Scully SP (2003) Treatment of osseous metastases in patients with renal cell carcinoma. Clin Orthop 409:223–231

Dürr HR, Maier M, Pfahler M et al (1999) Surgical treatment of osseous metastases in patients with renal cell carcinoma. Clin Orthop 367:283–290

Althausen P, Althausen A, Jennings LC, Mankin HJ (1997) Prognostic factors and surgical treatment of osseous metastases secondary to renal cell carcinoma. Cancer 80:1103–1109

Baloch KG, Grimer RJ, Carter SR, Tillman RM (2000) Radical surgery for the solitary bony metastasis from renal-cell carcinoma. J Bone Joint Surg Br 82:62–67

Fuchs B, Trousdale RT, Rock MG (2005) Solitary bony metastasis from renal cell carcinoma: significance of surgical treatment. Clin Orthop 431:187–192

Sampson E, Brierley JD, Le LW et al (2007) Clinical management and outcome of papillary and follicular (differentiated) thyroid cancer presenting with distant metastasis at diagnosis. Cancer 110:1451–1456

Haq M, Harmer C (2005) Differentiated thyroid carcinoma with distant metastases at presentation: prognostic factors and outcome. Clin Endocrinol 63:87–93

Papotti M, Kalebic T, Volante M et al (2006) Bone sialoprotein is predictive of bone metastases in resectable non-small-cell lung cancer: a retrospective case-control study. J Clin Oncol 24:4818–4824

Ibrahim T, Leong I, Sanchez-Sweatman O et al (2000) Expression of bone sialoprotein and osteopontin in breast cancer bone metastases. Clin Exp Metastasis 18:253–260

Bellahcene A, Kroll M, Liebens F, Castronovo V (1996) Bone sialoprotein expression in primary human breast cancer is associated with bone metastases development. J Bone Miner Res 11:665–670

Diel IJ, Solomayer EF, Seibel MJ et al (1999) Serum bone sialoprotein in patients with primary breast cancer is a prognostic marker for subsequent bone metastasis. Clin Cancer Res 5:3914–3919

Demers LM, Costa L, Lipton A (2003) Biochemical markers and skeletal metastases. Clin Orthop 415[Suppl]:138–147

Costa L, Demers LM, Gouveia-Oliveira A et al (2002) Prospective evaluation of the peptide-bound collagen type I cross-links N-telopeptide and C-telopeptide in predicting bone metastases status. J Clin Oncol 20:850–856

Coleman RE, Major P, Lipton A et al (2005) Predictive value of bone resorption and formation markers in cancer patients with bone metastases receiving the bisphosphonate zoledronic acid. J Clin Oncol 23:4925–4935

Brown JE, Cook RJ, Major P et al (2005) Bone turnover markers as predictors of skeletal complications in prostate cancer, lung cancer and other solid tumors. J Natl Cancer Inst 97:59–69